banner
Trastuzumab-modified toxin protein-encapsulated PEGylated immunoliposomes
Inquiry

Cat. No.: X26-05-ZQ2037

Trastuzumab-modified toxin protein-encapsulated PEGylated immunoliposomes

Synonym: Trastuzumab-modified toxin protein PEGylated immunoliposomes; Trastuzumab-functionalized toxin protein PEG stealth LPs; Trastuzumab toxin protein PEGylated immunoliposomes

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This highly complex macromolecular system features trastuzumab-modified toxin protein-encapsulated polyethylene glycol modified immunoliposomes. The structural matrix encapsulates a macromolecular cytotoxic toxin protein within its central aqueous core, while the exterior lipid bilayer is integrated with polyethylene glycol polymer-lipid conjugates and functionalized with anti-human epidermal growth factor receptor 2 (HER2) trastuzumab monoclonal antibodies linked via covalent polymer anchors. This dual-functional surface topography balances a dense target-mimetic ligand array with a protective hydrophilic steric shield, completely preventing physical vesicle aggregation and isolating the active protein core.
Source
Custom synthesis
Functional Group
Trastuzumab; Toxin protein
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.